As of 2024-12-14, the Intrinsic Value of Biogen Inc (BIIB) is
251.84 USD. This Biogen valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 150.03 USD, the upside of Biogen Inc is
67.90%.
The range of the Intrinsic Value is 165.39 - 501.24 USD
251.84 USD
Intrinsic Value
Biogen Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
165.39 - 501.24 |
251.84 |
67.9% |
| DCF (Growth 10y) |
178.86 - 492.89 |
260.44 |
73.6% |
| DCF (EBITDA 5y) |
220.40 - 295.33 |
238.02 |
58.6% |
| DCF (EBITDA 10y) |
225.03 - 318.47 |
252.82 |
68.5% |
| Fair Value |
55.42 - 55.42 |
55.42 |
-63.06% |
| P/E |
192.12 - 344.94 |
278.03 |
85.3% |
| EV/EBITDA |
287.94 - 505.22 |
329.56 |
119.7% |
| EPV |
169.10 - 239.79 |
204.45 |
36.3% |
| DDM - Stable |
91.65 - 292.73 |
192.19 |
28.1% |
| DDM - Multi |
89.06 - 223.99 |
127.77 |
-14.8% |
Biogen Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
21,862.37 |
| Beta |
0.76 |
| Outstanding shares (mil) |
145.72 |
| Enterprise Value (mil) |
26,457.07 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.44% |
| Cost of Debt |
4.28% |
| WACC |
8.04% |